Your account is not claimed yet. You can sign up with ORCID to claim your account.

Zuzana Macek Jilkova (Zuzana Macek Jílková, Zuzana Macek Jílková, Z Macek-Jilkova)

ResearcherID Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 21

Top Venues

International journal of molecular sciences

Cancers

Cells

Biomedicines

This page only lists publications with an associated author ORCID identifier.

Publications

Domenico Iuso, Isabel Garcia-Saez, Yohann Cout, Yoshiki Yamaryo-Botté, Elisabetta Boeri Erba, Annie Adrait, Nour Zeaiter, Malgorzata Tokarska-Schlattner, Zuzana Macek Jilkova, Fayçal Boussouar, Sophie Barral, Luca Signor, Couturier Karine, Azadeh Hajmirza, Florent Chuffart, Ekaterina Bourova-Flin, Anne-Laure Vitte, Lisa Bargier, Denis Puthier, Thomas Decaens, Sophie Rousseaux, Cyrille Y Botté, Uwe Schlattner, Carlo Petosa, Saadi Khochbin
Nucleoside diphosphate kinases 1 and 2 regulate a protective liver response to a high-fat diet. Science advances 9 (36) (2023)
Julien Ghelfi, Thomas Decaens, Zuzana Macek Jilkova
Rat Model of Hepatocellular Carcinoma for Better Understanding Immune Effects of Transarterial Chemoembolization. Radiology (2022)
Keerthi Kurma, Ayca Zeybek Kuyucu, Gaël S Roth, Nathalie Sturm, Marion Mercey-Ressejac, Giovanni Abbadessa, Yi Yu, Herve Lerat, Patrice N Marche, Thomas Decaens, Zuzana Macek Jilkova
Effect of Novel AKT Inhibitor Vevorisertib as Single Agent and in Combination with Sorafenib on Hepatocellular Carcinoma in a Cirrhotic Rat Model. International journal of molecular sciences 23 (24) (2022)
Keerthi Kurma, Ayca Zeybek Kuyucu, Gaël S Roth, Nathalie Sturm, Marion Mercey-Ressejac, Giovanni Abbadessa, Yi Yu, Herve Lerat, Patrice N Marche, Thomas Decaens, Zuzana Macek Jilkova
Effect of Novel AKT Inhibitor Vevorisertib as Single Agent and in Combination with Sorafenib on Hepatocellular Carcinoma in a Cirrhotic Rat Model. International journal of molecular sciences 23 (24) (2022)
Lydie Carreres, Marion Mercey-Ressejac, Keerthi Kurma, Julien Ghelfi, Carole Fournier, Olivier Manches, Florent Chuffart, Sophie Rousseaux, Mélanie Minoves, Thomas Decaens, Herve Lerat, Zuzana Macek Jilkova
Chronic Intermittent Hypoxia Increases Cell Proliferation in Hepatocellular Carcinoma. Cells 11 (13) (2022)
Keerthi Kurma, Ayca Zeybek Kuyucu, Gaël S Roth, Nathalie Sturm, Marion Mercey-Ressejac, Giovanni Abbadessa, Yi Yu, Herve Lerat, Patrice N Marche, Thomas Decaens, Zuzana Macek Jilkova
Effect of Novel AKT Inhibitor Vevorisertib as Single Agent and in Combination with Sorafenib on Hepatocellular Carcinoma in a Cirrhotic Rat Model. International journal of molecular sciences 23 (24) (2022)
Zuzana Macek Jilkova
Gamma delta T cells in hepatocellular carcinoma: Sunrise of new therapy based on Vδ2 T cells? Clinical and translational medicine 12 (4) (2022)
Keerthi Kurma, Ayca Zeybek Kuyucu, Gaël S Roth, Nathalie Sturm, Marion Mercey-Ressejac, Giovanni Abbadessa, Yi Yu, Herve Lerat, Patrice N Marche, Thomas Decaens, Zuzana Macek Jilkova
Effect of Novel AKT Inhibitor Vevorisertib as Single Agent and in Combination with Sorafenib on Hepatocellular Carcinoma in a Cirrhotic Rat Model. International journal of molecular sciences 23 (24) (2022)
Marie-Ange Lespinasse, Kaiyao Wei, Justine Perrin, Matthias Winkler, Sieme Hamaidia, Alexis Leroy, Zuzana Macek Jilkova, Christian Philouze, Patrice N Marche, Carlo Petosa, Jérôme Govin, Anouk Emadali, Yung-Sing Wong
Enantioselective Approach for Expanding the Three-Dimensional Space of Tetrahydroquinoline to Develop BET Bromodomain Inhibitors. Chemistry (Weinheim an der Bergstrasse, Germany) 28 (64) (2022)
Keerthi Kurma, Ayca Zeybek Kuyucu, Gaël S Roth, Nathalie Sturm, Marion Mercey-Ressejac, Giovanni Abbadessa, Yi Yu, Herve Lerat, Patrice N Marche, Thomas Decaens, Zuzana Macek Jilkova
Effect of Novel AKT Inhibitor Vevorisertib as Single Agent and in Combination with Sorafenib on Hepatocellular Carcinoma in a Cirrhotic Rat Model. International journal of molecular sciences 23 (24) (2022)
Sonia Brun, Eloïne Bestion, Eric Raymond, Firas Bassissi, Zuzana Macek Jilkova, Soraya Mezouar, Madani Rachid, Marie Novello, Jennifer Tracz, Ahmed Hamaï, Gilles Lalmanach, Lise Vanderlynden, Raphael Legouffe, Jonathan Stauber, Thomas Schubert, Maximilian G Plach, Jérôme Courcambeck, Cyrille Drouot, Guillaume Jacquemot, Cindy Serdjebi, Gaël S Roth, Jean-Pierre Baudoin, Christelle Ansaldi, Thomas Decaens, Philippe Halfon
GNS561, a clinical-stage PPT1 inhibitor, is efficient against hepatocellular carcinoma via modulation of lysosomal functions. Autophagy (2021)
Keerthi Kurma, Olivier Manches, Florent Chuffart, Nathalie Sturm, Khaldoun Gharzeddine, Jianhui Zhang, Marion Mercey-Ressejac, Sophie Rousseaux, Arnaud Millet, Herve Lerat, Patrice N Marche, Zuzana Macek Jilkova, Thomas Decaens
DEN-Induced Rat Model Reproduces Key Features of Human Hepatocellular Carcinoma. Cancers 13 (19) (2021)
Lydie Carreres, Zuzana Macek Jilkova, Guillaume Vial, Patrice N Marche, Thomas Decaens, Hervé Lerat
Modeling Diet-Induced NAFLD and NASH in Rats: A Comprehensive Review. Biomedicines 9 (4) (2021)
Mariam Mroweh, Gaël S Roth, Thomas Decaens, Patrice N Marche, Herve Lerat, Zuzana Macek Jilkova
Targeting Akt in Hepatocellular Carcinoma and Its Tumor Microenvironment. International journal of molecular sciences 22 (4) (2021)
Zuzana Macek Jilkova, Marie Noelle Hilleret, Theophile Gerster, Nathalie Sturm, Marion Mercey-Ressejac, Jean-Pierre Zarski, Vincent Leroy, Patrice N Marche, Charlotte Costentin, Thomas Decaens
Increased Intrahepatic Expression of Immune Checkpoint Molecules in Autoimmune Liver Disease. Cells 10 (10) (2021)
Zuzana Macek Jilkova, Arnaud Seigneurin, Celine Coppard, Laurissa Ouaguia, Caroline Aspord, Patrice N Marche, Vincent Leroy, Thomas Decaens
Circulating IL-13 Is Associated with De Novo Development of HCC in HCV-Infected Patients Responding to Direct-Acting Antivirals. Cancers 12 (12) (2020)
Zuzana Macek Jilkova, Caroline Aspord, Thomas Decaens
Reply to Comment on "Jilkova, Z.M.; et al. Predictive Factors for Response to PD-1/PD-L1 Checkpoint Inhibition in the Field of Hepatocellular Carcinoma: Current Status and Challenges" Cancers 2019, 11, 1554. Cancers 12 (9) (2020)
Lucile Dumolard, Julien Ghelfi, Gael Roth, Thomas Decaens, Zuzana Macek Jilkova
Percutaneous Ablation-Induced Immunomodulation in Hepatocellular Carcinoma. International journal of molecular sciences 21 (12) (2020)
Zuzana Macek Jilkova, Keerthi Kurma, Thomas Decaens
Animal Models of Hepatocellular Carcinoma: The Role of Immune System and Tumor Microenvironment. Cancers 11 (10) (2019)
Zuzana Macek Jilkova, Caroline Aspord, Thomas Decaens
Predictive Factors for Response to PD-1/PD-L1 Checkpoint Inhibition in the Field of Hepatocellular Carcinoma: Current Status and Challenges. Cancers 11 (10) (2019)
S I Malov, I V Malov, V V Dvornichenko, R I Rasulov, A G Kuvshinov, Patrice N Marche, Thomas Decaens, Zuzana Macek Jilkova, N D Yushuk
[Application of alpha-fetoprotein and osteopontin combination for early diagnosis of hepatocellular carcinoma associated with hepatitis C.] Klinicheskaia laboratornaia diagnostika 64 (10) (2019)

Zuzana Macek Jilkova.css-eqlu8i{font-size:small;padding-left:4px;} (Zuzana Macek Jílková, Zuzana Macek Jílková, Z Macek-Jilkova)

Publication Activity (10 Years)

Top Topics

Top Venues

Zuzana Macek Jilkova (Zuzana Macek Jílková, Zuzana Macek Jílková, Z Macek-Jilkova)